Empagliflozin and metformin and Mogamulizumab-kpkc Intravenous
Determining the interaction of Empagliflozin and metformin and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and Metformin
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and metformin-Molindone
- Empagliflozin and metformin-Mometasone (Oral Inhalation)
- Empagliflozin and metformin-Mometasone and Formoterol
- Empagliflozin and metformin-Mometasone and formoterol Inhalation
- Empagliflozin and metformin-Mometasone Cream
- Empagliflozin and metformin-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Empagliflozin and Metformin Extended-Release Tablets
- Mogamulizumab-kpkc Intravenous-Empagliflozin and Metformin Tablets
- Mogamulizumab-kpkc Intravenous-Empliciti
- Mogamulizumab-kpkc Intravenous-Emsam
- Mogamulizumab-kpkc Intravenous-Emsam Transdermal
- Mogamulizumab-kpkc Intravenous-Emtricitabine